Patent JPS6179864A successfully refreshed from Google Patents.
Patent US4228156A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4228156A Expired / Lapsed US ⏱️ 0.0 years remaining

Synthetic peptides having pituitary growth hormone releasing activity

Assignee: SmithKline Beecham Corp
•
Filing: 1979-03-30
•
Granted: 1980-10-14
•
Expires: 1999-03-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel tripeptides having the following amino acid sequence X-Y-Z-E-G wherein X is selected from a group consisting of --NH 2 , --NHCH 3 , and --N(CH 3 ) 2 ; Y and Z are independently selected from a group consisting of D-tyrosine, D-tryptophan, and D-phenylalanine; E is selected from a group consisting of tyrosine, tryptohan, and phenylalanine; and G is a C-terminal functional group selected froma group consisting of amide, amide lower alkyl, amide di(lower alkyl), lower alkoxy, hydroxy, and carboxy and the lower ester derivatives thereof; and the pharmaceutically acceptable salts thereof. These peptides act directly on the pituitary to release growth hormone therefrom.

Inventors

  • 👤 Frank A. Momany

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 05:17
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/08; C07K5/0802; C07K5/0812; C07K14/00; C07K14/435; C07K14/575; C07K14/60; C07K5/10; C07K5/1024; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 111 words
A peptide having a formula X-D-Trp-Z-E-G and the pharmaceutically acceptable non-toxic acid addition salts thereof wherein X is selected from a group consisting of --NH 2 , --NHCH 3 , and --N(CH 3 ) 2 ; Z is selected from a group consisting of D-Trp and D-Phe; E is selected from a group consisting of Trp and Phe; and G is selected from a group consisting of --CONH 2 , --CONHR, --CONR 1 R 2 , --CH 2 OR, --CH 2 OH, --COOH, and --COOR, wherein each R, R 1 , and R 2 is independently selected from a group consisting of straight and branch alkyl groups containing 1-6 carbon atoms.
Claim 2
Dependent Claim 111 words
A peptide having a formula X-D-Trp-Z-E-G and the pharmaceutically acceptable non-toxic acid addition salts thereof wherein X is selected from a group consisting of --NH 2 , --NHCH 3 , and --N(CH 3 ) 2 ; Z is selected from a group consisting of D-Trp and D-Phe; E is selected from a group consisting of Trp and Phe; and G is selected from a group consisting of --CONH 2 , --CONHR, --CONR 1 R 2 , --CH 2 OR, --CH 2 OH, --COOH, and --COOR, wherein each R, R 1 , and R 2 is independently selected from a group consisting of straight and branch alkyl groups containing 1-6 carbon atoms.
Claim 3
Dependent Claim 9 words
The peptide of claim 1 of the formula X-D-Trp-D-Trp-Trp-G.
Claim 4
Dependent Claim 9 words
The peptide of claim 1 of the formula X-D-Trp-D-Trp-Phe-G.
Claim 5
Dependent Claim 9 words
The peptide of claim 1 of the formula X-D-Trp-D-Phe-Trp-G.
Claim 6
Dependent Claim 9 words
The peptide of claim 1 of the formula X-D-Trp-D-Phe-Phe-G.
Claim 7
Dependent Claim 10 words
The peptide of claim 1 of the formula H.sub.2 N-D-Trp-D-Trp-Phe-CONH
Claim 8
Dependent Claim 30 words
The peptide of claims 2-5 or 1 wherein each R, R 1 , and R 2 is independently selected from the group consisting of alkyl groups containing 1-2 carbon atoms.
Claim 9
Dependent Claim 13 words
The peptide of claims 2-5 or 1 wherein G is --CONH 2 .
Claim 10
Independent Claim 21 words
A method of releasing growth hormone from a pituitary comprising contacting said pituitary with the peptide of claims 2-6 or 1.
Claim 11
Independent Claim 27 words
A method of releasing growth hormone from a pituitary comprising contacting said pituitary with the peptide of claims 2-5 or 1 wherein G is --CONH 2 .
Claim 12
Dependent Claim 15 words
A compound of the formula Boc-D-Trp-D-Trp-Phe-® wherein Boc is t-butyloxycarbonyl; and ® is benzhydrylamine resin.
Claim 13
Dependent Claim 15 words
A compound of the formula Boc-D-Trp-D-Trp-Phe-® wherein Boc is t-butyloxycarbonyl; and ® is benzhydrylamine resin.

References Cited (Backward Citations)

US3479333A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-10-14 1984-04-14 1984-10-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-10-14 1988-04-14 1988-10-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-10-14 1992-04-14 1992-10-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag